Posttransplant lymphoproliferative disease after heart transplantation on Sandimmune therapy: treatment with interferon alfa-2b and intravenous immunoglobulin

Transplant Proc. 1994 Oct;26(5):2660-1.

Authors

G Ippoliti¹, L Martinelli, F Lorenzutti, S Incardona, M Negri, P Balduzzi, B Rovati, E Ascari, M Viganò

Affiliation

¹ Clinica Medica II, RCCS S. Matteo, Pavia, Italy.

PMID: 7524218

No abstract available

Publication types

Case Reports

MeSH terms

Antigens, CD / blood
Biomarkers / blood
Cyclosporine / adverse effects*
Granulocyte Colony-Stimulating Factor / blood
Heart Transplantation / immunology*
Heart Transplantation / physiology
Humans
Immunoglobulins, Intravenous / therapeutic use*
Interferon alpha-2
Interferon-alpha / therapeutic use*
Lymphoproliferative Disorders / etiology*
Lymphoproliferative Disorders / therapy
Receptors, IgE / analysis
Receptors, Interleukin-2 / analysis
Recombinant Proteins
beta 2-Microglobulin / analysis

Substances

Antigens, CD
Biomarkers
Immunoglobulins, Intravenous
Interferon alpha-2
Interferon-alpha
Receptors, IgE
Receptors, Interleukin-2
Recombinant Proteins
beta 2-Microglobulin
Granulocyte Colony-Stimulating Factor
Cyclosporine